LG
Therapeutic Areas
USV Biologics Division Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Insulin Aspart Biosimilar | Diabetes Mellitus | Commercial |
| Metformin API | Type 2 Diabetes | Commercial |
| Human Growth Hormone Biosimilar | Growth Hormone Deficiency | Phase 2 |
| Monoclonal Antibody Biosimilar (Anti‑TNF) | Rheumatoid Arthritis | Phase 1 |
Leadership Team at USV Biologics Division
PT
Prashant Tewari
Managing Director
JD
Jayant Dwivedy
Executive Director & COO
DA
Dr. Aneesha Gandhi Tewari
Director, R&D